Ratan has more than 25 years of Research & Development expertise in Pharma and Biotech across the US, Sweden and India. He is Vice President and Global Head of Business Development & Licensing in BioPharmaceuticals at AstraZeneca and is responsible for BD in Cardiovascular, Renal, metabolism, Respiratory, Immunology and Neuroscience therapy areas spanning from all phases of early Discovery to Commercial partnering, as well as academic collaborations. Over the years, Ratan has made a significant impact on the portfolio with in-licensing assets, acquisitions and establishing large strategic partnerships. Ratan has served JSC chair of these partnerships, SAB at Univ. of Oslo and adjunct Professor at Karolinska University, Sweden. Between 2012-2014, Ratan was SVP, Head of R&D at Jubilant. Ratan joined Zeneca in Wilmington in 1997 from Cephalon and has held organisational leadership positions, led project teams to clinical decisions in small molecule, biologics and protein therapeutics. He trained at Johns Hopkins University, School of Medicine and has authored over 65 publications and 17 patents. Ratan is passionate about making a positive impact on the portfolio and a difference to patients.